Posted by & filed under Company Analysis, Governments & Regulators, Growth & Valuation, Industry Analysis, Personal Finance.

Description: A tentative settlement announced Wednesday over the role Purdue Pharma played in the nation’s opioid addiction crisis falls short of the far-reaching national settlement the OxyContin maker had been seeking for months. But litigation is sure to continue against the company and the family that owns it.

Source: CBS.com – video report

Date: Sep 11, 2019

Link: https://www.cbsnews.com/news/purdue-pharma-settlement-oxycontin-maker-reaches-tentative-deal-opioid-crisis-today-2019-09-11/

Questions for discussion:

  • What is the message presented here to the players involved?
  • which other industries face similar issues?
  • What are the ethical issues that the industry needs to consider?

Leave a Reply

Your email address will not be published.